CNCR

Fund Description
The Loncar Cancer Immunotherapy ETF seeks to track the LCINDX index. It is made up of a basket of companies that develop therapies to treat cancer by harnessing the body s own immune system. Immunotherapy is a transformational field within the biotechnology space that is expected to become the foundational treatment for cancer over the next ten years. A sector ETF focusing on a unique technology like cancer immunotherapy allows investors to focus on interest areas more precisely than broad indices. LCINDX is an equal-weighted index containing both large pharmaceutical and growth-oriented biotechnology companies that are leading in this approach.
Fund Profile
Fund Name Loncar Cancer Immunotherapy ETF
Fund Exchange Ticker CNCR
Fund Sponsor Exchange Traded Concepts
Fund ISIN US26922A8264
Net Expense Ratio 0.79 %
Fund Inception Date 13 October 2015
Fund Legal Structure ETF (Open end fund)
Exchange NASDAQ
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name Loncar Cancer Immunotherapy Index
Index Provider Loncar Investments
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 28 October 2020
Asset Under Management 38.69 Million (USD)
1 Month Total Return -1.86 %
Year To Date Return 13.82 %
1 Year Total Return 35.29 %
3 Year Annualized Total Return 3.03 %
NAV 26.6862
Share Outstanding 1,450,000
Top 10 Holdings (28 October 2020)
Constituent Name Constituent Ticker Constituent Type Weighting
REPLIMUNE GROUP INC REPL EQUI 0.0678000000
BEIGENE LTD-ADR BGNE EQUI 0.0569000000
TRILLIUM THERAPEUTICS INC TRIL EQUI 0.0500000000
BIONTECH SE-ADR BNTX EQUI 0.0496000000
CRISPR THERAPEUTICS AG CRSP EQUI 0.0493000000
FATE THERAPEUTICS INC FATE EQUI 0.0469000000
XENCOR INC XNCR EQUI 0.0408000000
IOVANCE BIOTHERAPEUTICS INC IOVA EQUI 0.0373000000
ZYMEWORKS INC ZYME EQUI 0.0360000000
ARGENX SE - ADR ARGX EQUI 0.0359000000